ALPMF
Price
$11.48
Change
+$0.38 (+3.42%)
Updated
Aug 19 closing price
Capitalization
19.67B
GRFS
Price
$9.87
Change
+$0.07 (+0.71%)
Updated
Aug 28 closing price
Capitalization
8.55B
69 days until earnings call
Interact to see
Advertisement

ALPMF vs GRFS

Header iconALPMF vs GRFS Comparison
Open Charts ALPMF vs GRFSBanner chart's image
Astellas Pharma
Price$11.48
Change+$0.38 (+3.42%)
Volume$1.07K
Capitalization19.67B
Grifols SA
Price$9.87
Change+$0.07 (+0.71%)
Volume$755.23K
Capitalization8.55B
ALPMF vs GRFS Comparison Chart in %
Loading...
ALPMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GRFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALPMF vs. GRFS commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALPMF is a Buy and GRFS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ALPMF: $11.48 vs. GRFS: $9.87)
Brand notoriety: ALPMF and GRFS are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ALPMF: 106% vs. GRFS: 73%
Market capitalization -- ALPMF: $19.67B vs. GRFS: $8.55B
ALPMF [@Pharmaceuticals: Major] is valued at $19.67B. GRFS’s [@Pharmaceuticals: Major] market capitalization is $8.55B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $656.17B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $88.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALPMF’s FA Score shows that 1 FA rating(s) are green whileGRFS’s FA Score has 1 green FA rating(s).

  • ALPMF’s FA Score: 1 green, 4 red.
  • GRFS’s FA Score: 1 green, 4 red.
According to our system of comparison, both ALPMF and GRFS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALPMF’s TA Score shows that 4 TA indicator(s) are bullish while GRFS’s TA Score has 3 bullish TA indicator(s).

  • ALPMF’s TA Score: 4 bullish, 4 bearish.
  • GRFS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ALPMF is a better buy in the short-term than GRFS.

Price Growth

ALPMF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while GRFS (@Pharmaceuticals: Major) price change was -2.08% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.92%. For the same industry, the average monthly price growth was +1.19%, and the average quarterly price growth was +11.79%.

Reported Earning Dates

GRFS is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.92% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALPMF($19.7B) has a higher market cap than GRFS($8.55B). ALPMF has higher P/E ratio than GRFS: ALPMF (59.95) vs GRFS (19.18). GRFS YTD gains are higher at: 37.180 vs. ALPMF (16.430). ALPMF has higher annual earnings (EBITDA): 270B vs. GRFS (1.62B). ALPMF has more cash in the bank: 329B vs. GRFS (566M). GRFS has less debt than ALPMF: GRFS (8.82B) vs ALPMF (927B). ALPMF has higher revenues than GRFS: ALPMF (1.77T) vs GRFS (7.45B).
ALPMFGRFSALPMF / GRFS
Capitalization19.7B8.55B230%
EBITDA270B1.62B16,687%
Gain YTD16.43037.18044%
P/E Ratio59.9519.18313%
Revenue1.77T7.45B23,798%
Total Cash329B566M58,127%
Total Debt927B8.82B10,511%
FUNDAMENTALS RATINGS
ALPMF vs GRFS: Fundamental Ratings
ALPMF
GRFS
OUTLOOK RATING
1..100
4973
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
22
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4347
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALPMF's Valuation (8) in the null industry is in the same range as GRFS (22) in the Pharmaceuticals Major industry. This means that ALPMF’s stock grew similarly to GRFS’s over the last 12 months.

ALPMF's Profit vs Risk Rating (100) in the null industry is in the same range as GRFS (100) in the Pharmaceuticals Major industry. This means that ALPMF’s stock grew similarly to GRFS’s over the last 12 months.

ALPMF's SMR Rating (100) in the null industry is in the same range as GRFS (100) in the Pharmaceuticals Major industry. This means that ALPMF’s stock grew similarly to GRFS’s over the last 12 months.

ALPMF's Price Growth Rating (43) in the null industry is in the same range as GRFS (47) in the Pharmaceuticals Major industry. This means that ALPMF’s stock grew similarly to GRFS’s over the last 12 months.

ALPMF's P/E Growth Rating (100) in the null industry is in the same range as GRFS (100) in the Pharmaceuticals Major industry. This means that ALPMF’s stock grew similarly to GRFS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALPMFGRFS
RSI
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
62%
Bullish Trend 1 day ago
71%
Momentum
ODDS (%)
Bullish Trend 1 day ago
52%
Bearish Trend 1 day ago
64%
MACD
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
70%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
50%
Bearish Trend 1 day ago
72%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
48%
Bearish Trend 1 day ago
71%
Advances
ODDS (%)
N/A
Bullish Trend 16 days ago
73%
Declines
ODDS (%)
N/A
Bearish Trend 9 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
70%
Aroon
ODDS (%)
Bullish Trend 1 day ago
56%
Bullish Trend 1 day ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
ALPMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GRFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CICAX65.640.28
+0.43%
American Funds Invmt Co of Amer 529A
FSMEX60.13N/A
N/A
Fidelity Select Medical Tech and Devcs
EIFGX31.19N/A
N/A
Eaton Vance Focused Growth Opps I
GSRRX11.70N/A
N/A
Goldman Sachs Rising Dividend Gr R
INTIX13.26N/A
N/A
Voya International Index Port S

ALPMF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALPMF has been loosely correlated with ALPMY. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ALPMF jumps, then ALPMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALPMF
1D Price
Change %
ALPMF100%
N/A
ALPMY - ALPMF
38%
Loosely correlated
+0.82%
JNJ - ALPMF
13%
Poorly correlated
-0.76%
GRFS - ALPMF
10%
Poorly correlated
+0.71%
AZNCF - ALPMF
8%
Poorly correlated
-1.53%
ABBV - ALPMF
5%
Poorly correlated
-0.07%
More

GRFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GRFS has been closely correlated with GIKLY. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if GRFS jumps, then GIKLY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRFS
1D Price
Change %
GRFS100%
+0.71%
GIKLY - GRFS
68%
Closely correlated
N/A
GIFOF - GRFS
37%
Loosely correlated
N/A
PFE - GRFS
28%
Poorly correlated
-1.87%
BIIB - GRFS
27%
Poorly correlated
-2.72%
GILD - GRFS
26%
Poorly correlated
-1.19%
More